https://www.barrons.com/articles/sanofi-regeneron-stocks-drug-collaboration-dupixent-51569250357 Guggenheim analysts went on a tear on Monday morning, upgrading both Sanofi and Regeneron in part …

More Sanofi and Regeneron Stocks Will Gain Because Dupixent Collaboration is Big, Analysts Say Videos